Combination therapy with All-trans Retinoic Acid (ATRA) and Ursodeoxycholic acid (UDCA) in Primary Sclerosing Cholangitis (PSC) Human Pilot Study
What is the purpose of this trial?
To conduct a feasibility pilot study to determine the efficacy and safety of ATRA in combination with UDCA in patients with PSC.
Click here for detailed information about who can participate in this trial.
- Yale University School of Medicine
- Last Updated:
- Study HIC#: